Trial intelligence / Profile preview

Age-related dose-finding study of remimazolam for induction of general anesthesia in female adults

KCT0008120Phase 4Completed

Sponsor
Ajou University Hospital
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of remimazolam, sponsored by Ajou University Hospital. Primary endpoints: EC50 for anesthesia induction and EC95 for anesthesia induction. Started Feb 2023; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on KCT0008120.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008120.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call